Catalysts for Janssen Therapeutics
248 tracked
Oct 21, 2014
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Oct 21, 2014
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Sep 15, 2014
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Aug 11, 2014
approval
CONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Mar 28, 2014
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Mar 28, 2014
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Mar 6, 2014
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Feb 13, 2014
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jan 29, 2014
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Jan 29, 2014
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Jan 7, 2014
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Dec 19, 2013
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
Dec 12, 2013
approval
CONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Jul 30, 2013
approval
CONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Jul 25, 2013
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Jun 12, 2013
approval
CONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Jun 5, 2013
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
May 24, 2013
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
May 6, 2013
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
May 3, 2013
approval
CONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
Janssen Therapeutics
→
Mar 1, 2013
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Jan 31, 2013
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Nov 2, 2012
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Nov 2, 2012
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Nov 2, 2012
approval
XARELTO (RIVAROXABAN) — FDA approval
Janssen Therapeutics
→
Oct 29, 2012
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Oct 29, 2012
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Aug 12, 2011
approval
HALDOL (HALOPERIDOL DECANOATE) — FDA approval
Janssen Therapeutics
→
Jul 15, 2011
approval
TOPAMAX (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→
Jul 15, 2011
approval
TOPAMAX SPRINKLE (TOPIRAMATE) — FDA approval
Janssen Therapeutics
→